|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar
|
|
2
|
Kuramitsu Y, Miyamoto H, Tanaka T, Zhang
X, Fujimoto M, Ueda K, Tanaka T, Hamano K and Nakamura K: Proteomic
differential display analysis identified upregulated astrocytic
phosphoprotein PEA-15 in human malignant pleural mesothelioma cell
lines. Proteomics. 9:5078–5089. 2009. View Article : Google Scholar
|
|
3
|
Luk JM, Lam CT, Siu AF, Lam BY, Ng IO, Hu
MY, Che CM and Fan ST: Proteomic profiling of hepatocellular
carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27,
Hsp70, GRP78) up-regulation and their associated prognostic values.
Proteomics. 6:1049–1057. 2006. View Article : Google Scholar
|
|
4
|
Roth U, Razawi H, Hommer J, Engelmann K,
Schwientek T, Müller S, Baldus SE, Patsos G, Corfield AP, Paraskeva
C and Hanisch FG: Differential expression proteomics of human
colorectal cancer based on a syngeneic cellular model for the
progression of adenoma to carcinoma. Proteomics. 10:194–202. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kuramitsu Y, Harada T, Takashima M,
Yokoyama Y, Hidaka I, Iizuka N, Toda T, Fujimoto M, Zhang X,
Sakaida I, et al: Increased expression and phosphorylation of liver
glutamine synthetase in well-differentiated hepatocellular
carcinoma tissues from patients infected with hepatitis C virus.
Electrophoresis. 27:1651–1658. 2006. View Article : Google Scholar
|
|
6
|
Tanaka T, Kuramitsu Y, Fujimoto M, Naito
S, Oka M and Nakamura K: Downregulation of two isoforms of
ubiquitin carboxyl-terminal hydrolase isozyme L1 correlates with
high metastatic potentials of human SN12C renal cell carcinoma cell
clones. Electrophoresis. 29:2651–2659. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kuramitsu Y, Hayashi E, Okada F, Tanaka T,
Zhang X, Ueyama Y and Nakamura K: Proteomic analysis for nuclear
proteins related to tumour malignant progression: a comparative
proteomic study between malignant progressive cells and regressive
cells. Anticancer Res. 30:2093–2099. 2010.
|
|
8
|
Kuramitsu Y, Baron B, Yoshino S, Zhang X,
Tanaka T, Yashiro M, Hirakawa K, Oka M and Nakamura K: Proteomic
differential display analysis shows up-regulation of 14–3–3 protein
sigma in human scirrhous-type gastric carcinoma cells. Anticancer
Res. 30:4459–4465. 2010.
|
|
9
|
Kuramitsu Y, Taba K, Ryozawa S, Yoshida K,
Zhang X, Tanaka T, Maehara S, Maehara Y, Sakaida I and Nakamura K:
Identification of up- and down-regulated proteins in
gemcitabine-resistant pancreatic cancer cells using two-dimensional
gel electrophoresis and mass spectrometry. Anticancer Res.
30:3367–3372. 2010.
|
|
10
|
Kuramitsu Y, Hayashi E, Okada F, Zhang X,
Tanaka T, Ueyama Y and Nakamura K: Staining with highly sensitive
Coomassie brilliant blue SeePico™ stain after Flamingo™ fluorescent
gel stain is useful for cancer proteomic analysis by means of
two-dimensional gel electrophoresis. Anticancer Res. 30:4001–4005.
2010.PubMed/NCBI
|
|
11
|
Mori-Iwamoto S, Kuramitsu Y, Ryozawa S,
Mikuria K, Fujimoto M, Maehara S, Maehara Y, Okita K, Nakamura K
and Sakaida I: Proteomics finding heat shock protein 27 as a
biomarker for resistance of pancreatic cancer cells to gemcitabine.
Int J Oncol. 31:1345–1350. 2007.PubMed/NCBI
|
|
12
|
Volberg T, Geiger B, Kam Z, Pankov R,
Simcha I, Sabanay H, Coll JL, Adamson E and Ben-Ze’ev A: Focal
adhesion formation by F9 embryonal carcinoma cells after vinculin
gene disruption. J Cell Sci. 108:2253–2260. 1995.PubMed/NCBI
|
|
13
|
Xu W, Baribault H and Adamson ED: Vinculin
knockout results in heart and brain defects during embryonic
development. Development. 125:327–337. 1998.PubMed/NCBI
|
|
14
|
Mikuriya K, Kuramitsu Y, Ryozawa S,
Fujimoto M, Mori S, Oka M, Hamano K, Okita K, Sakaida I and
Nakamura K: Expression of glycolytic enzymes is increased in
pancreatic cancerous tissues as evidenced by proteomic profiling by
two-dimensional electrophoresis and liquid chromatography-mass
spectrometry/mass spectrometry. Int J Oncol. 30:849–855. 2007.
|
|
15
|
Bakolitsa C, Cohen DM, Bankston LA, Bobkov
AA, Cadwell GW, Jennings L, Critchley DR, Craig SW and Liddington
RC: Structural basis for vinculin activation at sites of cell
adhesion. Nature. 430:583–586. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rüdiger M: Vinculin and alpha-catenin:
shared and unique functions in adherens junctions. Bioessays.
20:733–740. 1998.PubMed/NCBI
|
|
17
|
Rodríguez Fernández JL, Geiger B, Salomon
D, Sabanay I, Zöller M and Ben-Ze’ev A: Suppression of
tumorigenicity in transformed cells after transfection with
vinculin cDNA. J Cell Biol. 119:427–438. 1992.PubMed/NCBI
|
|
18
|
Subauste MC, Pertz O, Adamson ED, Turner
CE, Junger S and Hahn KM: Vinculin modulation of paxillin-FAK
interactions regulates ERK to control survival and motility. J Cell
Biol. 165:371–381. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Frisch SM and Francis H: Disruption of
epithelial cell-matrix interactions induces apoptosis. J Cell Biol.
124:619–626. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ruiz C, Holz DR, Oeggerli M, Schneider S,
Gonzales IM, Kiefer JM, Zellweger T, Bachmann A, Koivisto PA, Helin
HJ, et al: Amplification and overexpression of vinculin are
associated with increased tumour cell proliferation and progression
in advanced prostate cancer. J Pathol. 223:543–552. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thorsen K, Sørensen KD, Brems-Eskildsen
AS, Modin C, Gaustadnes M, Hein AM, Kruhøffer M, Laurberg S, Borre
M, Wang K, et al: Alternative splicing in colon, bladder, and
prostate cancer identified by exon array analysis. Mol Cell
Proteomics. 7:1214–1224. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ziegler WH, Liddington RC and Critchley
DR: The structure and regulation of vinculin. Trends Cell Biol.
16:453–460. 2006. View Article : Google Scholar : PubMed/NCBI
|
